Mirae Asset Global Etfs Holdings Ltd. Ikena Oncology, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,270 shares of IKNA stock, worth $27,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,270Holding current value
$27,008% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
73Shares Held
31.2MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.33 Million1.1% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$7.92 Million0.24% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.79 Million2.8% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.88 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.73 Million4.84% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $60.2M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...